Goldman Sachs BDC Inc
For the period ended Mar 31, 2024. Filed May 7, 2024.
View on SEC.govAbout this filing
A company's report for each of its first three quarters. The financial statements are not audited. It shows how the business has moved since the last annual report, and what management says changed.
Mar 31, 2024 · Filed May 7, 2024
GSBD$8.58-0.7%Stored close · as of Nov 9, 2026
Extracted filing text, with the paragraph anchors used by the comparison.
See the whole filing, with its images and exhibitsContents
Consolidated Statements of Cash Flows
| For the Three Months Ended | ||
|---|---|---|
| March 31,2024 | March 31,2023 | |
| Cash flows from operating activities: | ||
| Net increase in net assets from operations: | $42,452 | $28,063 |
| Adjustments to reconcile net increase (decrease) in net assets from operations to net cash provided by (used for) operating activities: | ||
| Purchases of investments | (138,966) | (43,021) |
| Payment-in-kind interest capitalized | (15,302) | (8,310) |
| Investments in affiliated money market fund, net | (499) | — |
| Proceeds from sales of investments and principal repayments | 114,611 | 30,455 |
| Net realized (gain) loss | 16,988 | 36,261 |
| Net change in unrealized (appreciation) depreciation on investments | 3,071 | (18,215) |
| Net change in unrealized (appreciation) depreciation on foreign currency forward contracts and transactions | (72) | 30 |
| Amortization of premium and accretion of discount, net | (6,188) | (5,856) |
| Amortization of deferred financing and debt issuance costs | 1,787 | 1,536 |
| Change in operating assets and liabilities: | ||
| (Increase) decrease in receivable for investments sold | — | (421) |
| (Increase) decrease in interest and dividends receivable | 320 | 1,984 |
| (Increase) decrease in other assets | 256 | (601) |
| Increase (decrease) in interest and other debt expenses payable | (5,760) | (7,483) |
| Increase (decrease) in management fees payable | 24 | (142) |
| Increase (decrease) in incentive fees payable | (2,159) | 20,316 |
| Increase (decrease) in accrued expenses and other liabilities | (3,525) | (2,322) |
| Net cash provided by (used for) operating activities | $7,038 | $32,274 |
| Cash flows from financing activities: | ||
| Proceeds from issuance of common stock (net of underwriting costs) | $36,566 | $98,085 |
| Offering costs paid | (194) | (28) |
| Distributions paid | (47,563) | (44,593) |
| Deferred financing and debt issuance costs paid | (7,400) | (115) |
| Borrowings on debt | 502,582 | 68,937 |
| Repayments of debt | (491,000) | (147,000) |
| Net cash provided by (used for) financing activities | $(7,009) | $(24,714) |
| Net increase (decrease) in cash | $29 | $7,560 |
| Effect of foreign exchange rate changes on cash and cash equivalents | (73) | 11 |
| Cash, beginning of period | 52,363 | 39,602 |
| Cash, end of period | $52,319 | $47,173 |
| Supplemental and non-cash activities | ||
| Interest expense paid | $30,934 | $32,729 |
| Accrued but unpaid excise tax expense | $1,778 | $1,076 |
| Accrued but unpaid distributions | $50,447 | $49,258 |
| Reinvestment of stockholder distributions | $1,741 | $1,690 |
| Exchange of investments | $59,464 | $— |
The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.